GB1471262A - Virus growth - Google Patents

Virus growth

Info

Publication number
GB1471262A
GB1471262A GB119973A GB119973A GB1471262A GB 1471262 A GB1471262 A GB 1471262A GB 119973 A GB119973 A GB 119973A GB 119973 A GB119973 A GB 119973A GB 1471262 A GB1471262 A GB 1471262A
Authority
GB
United Kingdom
Prior art keywords
viruses
cell strain
nutrient
mink
nutrient medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB119973A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C VET Ltd
Original Assignee
C VET Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C VET Ltd filed Critical C VET Ltd
Priority to GB119973A priority Critical patent/GB1471262A/en
Publication of GB1471262A publication Critical patent/GB1471262A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1471262 Growing viruses C VET Ltd 25 March 1974 [9 Jan 1973] 1199/73 Heading C6F [Also in Division A5] Feline panleucopenia or mink enteritis viruses are grown in a nutrient medium comprising a mink tissue cell strain which contains actively dividing cells. The viruses may be inactivated or attenuated by serial passage in the cell strain to produce antigenic material, which may be incorporated in a vaccine. The cell strain may be of lung, kidney or heart of an adult, or preferably, foetal mink. The cells are rendered aseptic and disaggregated mechanically or enzymatically and cultured by serial passages in a nutrient medium until a diploid or heteroploid cell strain free from extraneous viruses, is produced and the cell strain is seeded with the virus either before or after mixing with nutrient medium. Where the nutrient is added after seeding, the culture is maintained at 20-40‹C for 0À5-2 hours before adding nutrient which is added at a rate of 10-50 ml/10<SP>6</SP> viable cells, after which incubation at 30-40‹C is carried out for 5-7 days. Harvesting is achieved by centrifuging to recover extracellular virus followed by treatment to break down all walls and centrifugation to recover all associated viruses.
GB119973A 1974-03-25 1974-03-25 Virus growth Expired GB1471262A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB119973A GB1471262A (en) 1974-03-25 1974-03-25 Virus growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB119973A GB1471262A (en) 1974-03-25 1974-03-25 Virus growth

Publications (1)

Publication Number Publication Date
GB1471262A true GB1471262A (en) 1977-04-21

Family

ID=9717885

Family Applications (1)

Application Number Title Priority Date Filing Date
GB119973A Expired GB1471262A (en) 1974-03-25 1974-03-25 Virus growth

Country Status (1)

Country Link
GB (1) GB1471262A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011865A1 (en) * 1978-11-30 1980-06-11 The Wellcome Foundation Limited Feline infectious peritonitis vaccine and process for its preparation
EP0011864A1 (en) * 1978-11-30 1980-06-11 The Wellcome Foundation Limited Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
WO1980001644A1 (en) * 1979-02-16 1980-08-21 Cornell Res Foundation Inc Heterotypic canine parvovirus vaccine
EP0027347A1 (en) * 1979-10-16 1981-04-22 Norden Laboratories, Inc. Feline infectious peritonitis virus, its preparation and vaccines containing it

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011865A1 (en) * 1978-11-30 1980-06-11 The Wellcome Foundation Limited Feline infectious peritonitis vaccine and process for its preparation
EP0011864A1 (en) * 1978-11-30 1980-06-11 The Wellcome Foundation Limited Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
WO1980001644A1 (en) * 1979-02-16 1980-08-21 Cornell Res Foundation Inc Heterotypic canine parvovirus vaccine
EP0023922A1 (en) * 1979-02-16 1981-02-18 Cornell Res Foundation Inc Heterotypic canine parvovirus vaccine.
EP0023922A4 (en) * 1979-02-16 1981-10-27 Cornell Res Foundation Inc Heterotypic canine parvovirus vaccine.
EP0027347A1 (en) * 1979-10-16 1981-04-22 Norden Laboratories, Inc. Feline infectious peritonitis virus, its preparation and vaccines containing it

Similar Documents

Publication Publication Date Title
Dawson et al. In vitro transformation of pneumococcal types: I. A technique for inducing transformation of pneumococcal types in vitro
Conti et al. Biology of budding bacteria III. Fine structure of Rhodomicrobium and Hyphomicrobium spp
ES8609459A1 (en) Process for the preparation of cellulose film, cellulose film produced thereby, artificial skin graft and its use.
Happold et al. The coli-tryptophan-indole reaction: Enzyme preparations and their action on tryptophan and some indole derivatives
Silver et al. Nitrogen fixation by the leaf-nodule endophyte of Psychotria bacteriophila
GB1471262A (en) Virus growth
Happold et al. The Coli-Tryptophan-Indole Reaction: II. The Non-Production of Tryptophanase in Media Containing Glucose
Nissen et al. Regulation of oxygen consumption in neuroblastoma cells: effects of differentiation and of potassium
US3704546A (en) Symbiotic fixation of atmospheric nitrogen
Walker et al. Photosynthetic oxygen evolution by isolated chloroplasts in the presence of carbon cycle intermediates
KR900702045A (en) How to prepare natural HIV GP 160
Albright et al. In vitro growth of Trypanosoma musculi in cellfree medium conditioned by rodent macrophages and mercaptoethanol
US3594284A (en) Lysostaphin fermentation with accelerated time cycle
CN109182245A (en) The cultural method of tobacco suspension cell
GB1492930A (en) Virus growth
Petkus et al. Pure spherules of Coccidioides immitis in continuous culture
GB930451A (en) Process for propagating rabies virus
Lambert et al. A study of cancer immunity by the method of cultivating tissues outside the body
ES385968A1 (en) Highly attenuated newcastle disease virus vaccine and production thereof
EA202190638A1 (en) METHOD FOR OBTAINING HEMOPHILIC TYPE VACCINE IN CONJUGATED
Loughheed The effect of nutrition on synnemata formation in Hirsutella gigantea Petch
KR900004069B1 (en) Process for the production of saponins from character-converted ginseing cell
YU46029B (en) PROCEDURE FOR THE PREPARATION OF A LIVE MUMPS VACCINE
Kleeman et al. Observed differences in CO2 requirements between mammalian and salmonid fish cell lines
KR920006496A (en) Method for preparing oral typhoid vaccine

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee